• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

叶酸和 S-腺苷甲硫氨酸治疗重性抑郁障碍。

Folates and S-adenosylmethionine for major depressive disorder.

机构信息

Harvard Medical School and Director of Center for Treatment-Resistant Depression, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

出版信息

Can J Psychiatry. 2012 Jul;57(7):406-13. doi: 10.1177/070674371205700703.

DOI:10.1177/070674371205700703
PMID:22762295
Abstract

Interest in nonpharmaceutical supplements for treating major depressive disorder (MDD) has increased significantly, both among patients and among clinicians during the past decades. Despite the large array of antidepressants (ADs) available, many patients continue to experience relatively modest response and remission rates, in addition to a burden of side effects that can hinder treatment compliance and acceptability. In this article, we review the literature on folates and S-adenosylmethionine (SAMe), 2 natural compounds linked in the 1-carbon cycle metabolic pathway, for which substantial evidence supports their involvement in mood disorders. Background information, efficacy data, proposed mechanisms of action, and side effects are reviewed. Based on existing data, supplementation with SAMe, as well as with various formulations of folates, appears to be efficacious and well tolerated in reducing depressive symptoms. Compared with other forms of folates, 5-methyltetrahydrofolate (L-methylfolate or 5-MTHF) may represent a preferable treatment option for MDD given its greater bioavailability in patients with a genetic polymorphism, and the lower risk of specific side effects associated with folic acid. Although further randomized controlled trials in this area appear warranted, SAMe and L-methylfolate may represent a useful addition to the AD armamentarium.

摘要

在过去几十年中,人们对治疗重度抑郁症 (MDD) 的非药物补充剂的兴趣显著增加,无论是在患者还是临床医生中。尽管有大量的抗抑郁药 (AD) 可用,但许多患者继续经历相对适度的反应和缓解率,此外还有副作用的负担,这可能会阻碍治疗的依从性和可接受性。在本文中,我们回顾了叶酸和 S-腺苷甲硫氨酸 (SAMe) 的文献,这两种天然化合物在 1 碳循环代谢途径中相互关联,有大量证据表明它们与情绪障碍有关。我们回顾了背景信息、疗效数据、提出的作用机制和副作用。基于现有数据,SAMe 以及各种形式的叶酸补充剂似乎在减轻抑郁症状方面是有效且耐受良好的。与其他形式的叶酸相比,5-甲基四氢叶酸 (L-甲基叶酸或 5-MTHF) 可能代表 MDD 的更优治疗选择,因为它在具有遗传多态性的患者中具有更高的生物利用度,并且与叶酸相关的特定副作用风险更低。尽管在这一领域进一步的随机对照试验似乎是必要的,但 SAMe 和 L-甲基叶酸可能代表 AD 武器库中的有用补充。

相似文献

1
Folates and S-adenosylmethionine for major depressive disorder.叶酸和 S-腺苷甲硫氨酸治疗重性抑郁障碍。
Can J Psychiatry. 2012 Jul;57(7):406-13. doi: 10.1177/070674371205700703.
2
Evidence for S-adenosyl-L-methionine (SAM-e) for the treatment of major depressive disorder.有证据表明 S-腺苷甲硫氨酸(SAM-e)可用于治疗重度抑郁症。
J Clin Psychiatry. 2009;70 Suppl 5:18-22. doi: 10.4088/JCP.8157su1c.04.
3
Folate augmentation of antidepressant response.叶酸增强抗抑郁反应。
Drugs Today (Barc). 2013 Dec;49(12):791-8. doi: 10.1358/dot.2013.49.12.2086138.
4
S-adenosyl-methionine in depression: a comprehensive review of the literature.抑郁症中的S-腺苷甲硫氨酸:文献综述
Curr Psychiatry Rep. 2003 Dec;5(6):460-6. doi: 10.1007/s11920-003-0085-2.
5
Discrepancy in response and remission rates for SAMe-treated patients in a double-blind, randomized clinical trial.在一项双盲随机临床试验中,接受S-腺苷甲硫氨酸治疗的患者在缓解率和应答率方面存在差异。
Am J Psychiatry. 2010 Dec;167(12):1533; author reply 1533. doi: 10.1176/appi.ajp.2010.10091252.
6
Folate in depression: efficacy, safety, differences in formulations, and clinical issues.抑郁症中的叶酸:疗效、安全性、配方差异及临床问题。
J Clin Psychiatry. 2009;70 Suppl 5:12-7. doi: 10.4088/JCP.8157su1c.03.
7
S-adenosyl methionine (SAMe) augmentation in major depressive disorder.S-腺苷甲硫氨酸(SAMe)在重度抑郁症中的增效作用。
Am J Psychiatry. 2010 Aug;167(8):889-91. doi: 10.1176/appi.ajp.2010.10040627.
8
Evidence for the use of l-methylfolate combined with antidepressants in MDD.在 MDD 中使用 L-甲基叶酸联合抗抑郁药的证据。
J Clin Psychiatry. 2011 Aug;72(8):e25. doi: 10.4088/JCP.11012tx1c.
9
Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.补充和替代医学治疗重度抑郁症:对患者特征、安慰剂反应率以及与标准抗抑郁药治疗结果的荟萃分析。
J Clin Psychiatry. 2010 Jun;71(6):682-8. doi: 10.4088/JCP.10r05976blu.
10
A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-L-methionine 1,4-butanedisulphonate (SAMe) versus imipramine in patients with major depressive disorder.一项关于肌肉注射 S-腺苷-L-蛋氨酸 1,4-丁二磺酸盐(SAMe)与丙咪嗪治疗重度抑郁症患者的双盲、随机平行组、疗效与安全性研究。
Int J Neuropsychopharmacol. 2002 Dec;5(4):287-94. doi: 10.1017/S1461145702003085.

引用本文的文献

1
Pharmacological Monotherapy for Depressive Disorders: Current and Future-A Narrative Review.抑郁症的药物单药治疗:现状与未来——一篇叙述性综述
Medicina (Kaunas). 2025 Mar 21;61(4):558. doi: 10.3390/medicina61040558.
2
Breeding of Saccharomyces cerevisiae with a High-Throughput Screening Strategy for Improvement of S-Adenosyl-L-Methionine Production.利用高通量筛选策略对酿酒酵母进行选育以提高 S-腺苷甲硫氨酸的产量。
Appl Biochem Biotechnol. 2024 Mar;196(3):1450-1463. doi: 10.1007/s12010-023-04622-7. Epub 2023 Jul 7.
3
The Efficacy of S-Adenosyl Methionine and Probiotic Supplementation on Depression: A Synergistic Approach.
S-腺苷甲硫氨酸和益生菌补充剂对抑郁症的疗效:协同作用的方法。
Nutrients. 2022 Jul 1;14(13):2751. doi: 10.3390/nu14132751.
4
Prediction of Suicidality According to Serum Folate Levels in Depressive Patients Receiving Stepwise Pharmacotherapy.接受逐步药物治疗的抑郁症患者血清叶酸水平对自杀倾向的预测
Front Psychiatry. 2021 Dec 2;12:747228. doi: 10.3389/fpsyt.2021.747228. eCollection 2021.
5
Mutual Correlation between Non-Coding RNA and S-Adenosylmethionine in Human Cancer: Roles and Therapeutic Opportunities.人类癌症中非编码RNA与S-腺苷甲硫氨酸的相互关系:作用及治疗机会
Cancers (Basel). 2021 Jun 29;13(13):3264. doi: 10.3390/cancers13133264.
6
Impact of Supplementation and Nutritional Interventions on Pathogenic Processes of Mood Disorders: A Review of the Evidence.补充和营养干预对心境障碍发病机制的影响:证据综述。
Nutrients. 2021 Feb 26;13(3):767. doi: 10.3390/nu13030767.
7
Modeling heritability of temperamental differences, stress reactivity, and risk for anxiety and depression: Relevance to research domain criteria (RDoC).气质差异、应激反应的遗传性建模,以及焦虑和抑郁的风险:与研究领域标准(RDoC)的相关性。
Eur J Neurosci. 2022 May;55(9-10):2076-2107. doi: 10.1111/ejn.15158. Epub 2021 Mar 24.
8
Resilience to Stress: Lessons from Rodents about Nature versus Nurture.抗压能力:啮齿类动物关于先天与后天的启示。
Neuroscientist. 2022 Jun;28(3):283-298. doi: 10.1177/1073858421989357. Epub 2021 Feb 10.
9
S-Adenosylmethionine Inhibits Cell Growth and Migration of Triple Negative Breast Cancer Cells through Upregulating MiRNA-34c and MiRNA-449a.S-腺苷甲硫氨酸通过上调 miRNA-34c 和 miRNA-449a 抑制三阴性乳腺癌细胞的生长和迁移。
Int J Mol Sci. 2020 Dec 30;22(1):286. doi: 10.3390/ijms22010286.
10
Mi-RNA-888-5p Is Involved in S-Adenosylmethionine Antitumor Effects in Laryngeal Squamous Cancer Cells.微小RNA-888-5p参与S-腺苷甲硫氨酸对喉鳞状癌细胞的抗肿瘤作用。
Cancers (Basel). 2020 Dec 7;12(12):3665. doi: 10.3390/cancers12123665.